Developing therapies to treat neurodegenerative diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Curasen is discovering and developing therapies to treat neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease and less common neurodegenerative disorders. Curasen develops small molecule drugs targeting a novel mechanism in the brain to modify disease pathology, and alleviate disabling symptoms. Curasen’s drugs are designed to activate certain receptor populations in the brain to compensate for critical neuronal and glial functions that have otherwise been lost due to degeneration.
Curasen Funding
Sign up to gain insights into Curasen funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Aug 26, 2024 | 6M | ||
| Series A Prime | Oct 11, 2023 | 3M | ||
| Series A Prime | Nov 01, 2022 | 15M | ||
| Series A Prime | Oct 21, 2021 | 18M | ||
| Series A Prime | Sep 18, 2018 | 27M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Curasen Management Team
Investors
Alta Partners
Alzheimer’s Drug Discovery Foundation (ADDF)
Johnson & Johnson Development Corp (JJDC)
Longitude Capital
New Leaf Venture Partners LLC
Pappas Capital, LLC
Tekla Capital Management LLC
Curasen Valuations & Financials
View real-time NPM data on Curasen stock including daily Curasen stock price estimates, valuation history, and historical share price information. Access Curasen financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Curasen pricing across six independent market signals. Looking for private company due diligence data sources on Curasen? Get in touch to learn more.
Similar Companies
like Curasen
Spring Health
Healthcare & Life Sciences
Mental healthcare solutions for employers and health plans.
ZocDoc
Healthcare & Life Sciences
Online appointment booking, reminders, paperwork services, and specialty care options.
Clarify
Healthcare & Life Sciences
Delivers actionable insights from complex medical data to support better care and operational decisions.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
TurtleTree
Healthcare & Life Sciences
Biotech company focused on creating sustainable and innovative nutrition solutions.
AnimalBiome
Healthcare & Life Sciences
Dedicated to improving the health of cats and dogs through microbiome science.
RefleXion Medical
Healthcare & Life Sciences
Develops a biologically-guided radiation therapy system for cancer treatment.
Cala Health
Healthcare & Life Sciences
Creates wearable neuromodulation devices for non-invasive, personalized therapies to manage chronic conditions.
FAQ
We have answers
Curasen stock does not trade on public stock exchanges. Curasen stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Curasen stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Curasen Stock does not trade on public stock exchanges. In order to sell Curasen shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Curasen does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Curasen share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Curasen stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Curasen stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Curasen stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Curasen is a private company and has not had an IPO. There is currently no Curasen IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Curasen IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
